JPS61100518A - ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤 - Google Patents

ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Info

Publication number
JPS61100518A
JPS61100518A JP59220565A JP22056584A JPS61100518A JP S61100518 A JPS61100518 A JP S61100518A JP 59220565 A JP59220565 A JP 59220565A JP 22056584 A JP22056584 A JP 22056584A JP S61100518 A JPS61100518 A JP S61100518A
Authority
JP
Japan
Prior art keywords
liposome
drug
dimyristoylphosphatidylcholine
arachidonic acid
main component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59220565A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0362696B2 (enExample
Inventor
Jun Mizutani
純 水谷
Seiji Shioda
塩田　聖士
Mitsuharu Inaba
光治 稲葉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP59220565A priority Critical patent/JPS61100518A/ja
Publication of JPS61100518A publication Critical patent/JPS61100518A/ja
Publication of JPH0362696B2 publication Critical patent/JPH0362696B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59220565A 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤 Granted JPS61100518A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59220565A JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59220565A JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Publications (2)

Publication Number Publication Date
JPS61100518A true JPS61100518A (ja) 1986-05-19
JPH0362696B2 JPH0362696B2 (enExample) 1991-09-26

Family

ID=16752979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59220565A Granted JPS61100518A (ja) 1984-10-22 1984-10-22 ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤

Country Status (1)

Country Link
JP (1) JPS61100518A (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS643115A (en) * 1987-06-26 1989-01-06 Dai Ichi Seiyaku Co Ltd Liposome preparation
JPS643114A (en) * 1987-06-25 1989-01-06 Dai Ichi Seiyaku Co Ltd Stable liposome water dispersion
JPH02504027A (ja) * 1987-05-22 1990-11-22 ザ　リポソーム　カンパニー，インコーポレイテッド プロスタグランジン‐脂質製剤
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
JPH04356421A (ja) * 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
DE4309579A1 (de) * 1993-03-24 1994-09-29 Sanol Arznei Schwarz Gmbh Pharmazeutische Zusammensetzung in Form eines Kits
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS567714A (en) * 1979-06-22 1981-01-27 Hoffmann La Roche Pharmaceutical medicine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS567714A (en) * 1979-06-22 1981-01-27 Hoffmann La Roche Pharmaceutical medicine

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504027A (ja) * 1987-05-22 1990-11-22 ザ　リポソーム　カンパニー，インコーポレイテッド プロスタグランジン‐脂質製剤
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
JPS643114A (en) * 1987-06-25 1989-01-06 Dai Ichi Seiyaku Co Ltd Stable liposome water dispersion
JPS643115A (en) * 1987-06-26 1989-01-06 Dai Ichi Seiyaku Co Ltd Liposome preparation
JPH04356421A (ja) * 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
DE4309579A1 (de) * 1993-03-24 1994-09-29 Sanol Arznei Schwarz Gmbh Pharmazeutische Zusammensetzung in Form eines Kits
US5681855A (en) * 1993-03-24 1997-10-28 Schwarz Pharma Ag PGE1 emulsion composition kit
DE4309579C3 (de) * 1993-03-24 2000-01-27 Sanol Arznei Schwarz Gmbh Pharmazeutische Zusammensetzung in Form einer Packung

Also Published As

Publication number Publication date
JPH0362696B2 (enExample) 1991-09-26

Similar Documents

Publication Publication Date Title
US5082664A (en) Prostaglandin-lipid formulations
US5262168A (en) Prostaglandin-lipid formulations
KR890004689B1 (ko) 인지질 및 미셀 입자 중에서 피포시킨 안트라사이클린 항악성종양제
US5683715A (en) Taxane-containing phosphatidylcholine liposomes
CA2681302C (en) Proliposomal and liposomal compositions of poorly water-soluble compounds
AU749499B2 (en) Method of forming liposomes
JPS60155109A (ja) リポソ−ム製剤
JPH0534334B2 (enExample)
JPH11507369A (ja) プレリポソーム凍結乾燥体から得られるサブミクロンリポソーム懸濁液
US20020182248A1 (en) Liposomes and liposomal dispersion
JP2018502870A (ja) トラネキサム酸の多小胞リポソーム処方物
JP2009507049A (ja) リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤
CA3018670A1 (en) Viscoelastic gel of liraglutide adapted for once-weekly or once bi-weekly administration
JPS61100518A (ja) ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
US20020058060A1 (en) Liposome for incorporating large amounts of hydrophobic substances
JP2844756B2 (ja) 脂肪乳剤
EP0160286B1 (en) Liposomes
JPH07108166A (ja) リポソーム
JP2653245B2 (ja) 脂肪乳剤
RU2217128C1 (ru) Препарат для местного применения при лечении туберкулеза легких и гнойно-воспалительных заболеваний
US20060030578A1 (en) Pharmaceutically active lipid based formulation of irinotecan
EP0190343A1 (en) Method for using nutrient-containing liposomes in hyperalimentation
AU6595396A (en) Reverse gels comprising a continuous fluorinated phase
JPH06502623A (ja) 安定なドキソルビシン／リポソーム組成物
JP2780755B2 (ja) プロスタグランジン‐脂質製剤